Skip to Content

Workers’ Compensation Board

Search menu

Subject Number 046-1440 Temporary Suspension of Lara Lynn Busch, N.P.

Subject Numbers Regarding Health Provider Authorizations

Authorization No. N550634-0W

September 7, 2021

Pursuant to Workers' Compensation Law Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised her authority to temporarily suspend Lara Lynn Busch, N.P.'s authorization to treat injured workers within the New York State workers' compensation system effective September 3, 2021. Ms. Busch's last known business address is:

Rochester Integrated Medicine
309 Exchange Boulevard
Rochester, New York 14608

The Chair's designee's investigation has revealed that the New York State Department of Education, Office of Professional Discipline, State Board for Nursing, has issued Order Nos. 32309 (R.N.) and 32310 (N.P.), wherein Ms. Busch admitted guilt to the specification of professional misconduct, including that, on or about and between November 13, 2018, and February 14, 2019, she called prescriptions in for herself to a pharmacy on approximately five occasions using the credentials of another practitioner. This resulted in a two-year stayed suspension and a two-year probationary period.

Therefore, the Chair believes that Ms. Busch may be guilty of misconduct as described in Education Law §6530(3), and that such misconduct would detrimentally affect the quality of care provided to injured workers.

Ms. Busch is prohibited from rendering treatment and care to injured workers, and from conducting reviews of records regarding variance requests pursuant to 12 NYCRR § 324.3(b)(2)(ii)(a), while her authorization is temporarily suspended. Reports submitted by Ms. Busch for services rendered prior to September 3, 2021 are valid but are invalid for any services rendered on or after that date. Requests to cross-examine Ms. Busch for services rendered prior to September 3, 2021, should not be denied due to the suspension of her authorization.

This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director's Office at 1 (800) 781-2362.

Clarissa M. Rodriguez
Chair